Literature DB >> 32561101

Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching.

So Hyun Kang1, YoungRok Choi2, Woohyung Lee3, Soyeon Ahn4, Jai Young Cho5, Yoo-Seok Yoon5, Ho-Seong Han5.   

Abstract

INTRODUCTION: Laparoscopic liver resection(LLR) for intrahepatic cholangiocarcinoma is debatable due to technical challenges associated with major hepatectomy and lymph node dissection. This study aims to analyze the long-term outcomes with propensity score matching.
METHODS: Patients who underwent liver resection for intrahepatic cholangiocarcinoma from August 2004 to October 2015 were enrolled. Those who had combined hepatocellular-cholangiocarcinoma and palliative surgery were excluded. Medical records were reviewed for postoperative outcome, recurrence, and survival. The 3-year disease-free survival(DFS) and 3-year overall survival(OS) were set as the primary endpoint, and 3-year disease-specific survival, 1-year OS, 1-year DFS, operative outcome, and postoperative complications were secondary endpoints.
RESULTS: A total of 91 patients were enrolled with 61 in the open group and 30 in the laparoscopic group. Propensity score matching included 24 patients in both groups. In total, the 3-year OS was 81.2% in the open group and 76.7% in the laparoscopic group(p = 0.621). For 3-year DFS, open was 42.5% and laparoscopic was 65.6%(p = 0.122). Mean operation time for the open group was 343.2 ± 106.0 min and laparoscopic group was 375.2 ± 204.0 min(p = 0.426). Hospital stay was significantly shorter in the laparoscopic group(9.8 ± 5.1 days) than the open group(18.3 ± 14.7, p=<0.001). There was no difference in complication rate and 30-day readmission rate. Tumor size, nodularity, and presence of perineural invasion showed an independent association with the 3-year DFS in multivariate analysis.
CONCLUSION: Laparoscopic liver resection for intrahepatic cholangiocarcinoma is technically feasible and safe, providing short-term benefits without increasing complications or affecting long-term survival.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Cholangiocarcinoma; Hepatectomy; Laparoscopy; Minimally invasive surgical procedures

Mesh:

Year:  2020        PMID: 32561101     DOI: 10.1016/j.suronc.2020.01.001

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  7 in total

1.  Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.

Authors:  Omid Salehi; Vera Kazakova; Eduardo A Vega; Onur C Kutlu; Sylvia V Alarcon; Richard Freeman; Olga Kozyreva; Claudius Conrad
Journal:  Surg Endosc       Date:  2021-11-08       Impact factor: 3.453

Review 2.  Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma.

Authors:  Nikolaos Machairas; Ioannis D Kostakis; Dimitrios Schizas; Stylianos Kykalos; Nikolaos Nikiteas; Georgios C Sotiropoulos
Journal:  Updates Surg       Date:  2020-11-21

Review 3.  Approach to Resectable Biliary Cancers.

Authors:  Kimberly Washington; Flavio Rocha
Journal:  Curr Treat Options Oncol       Date:  2021-09-15

4.  Laparoscopic Versus Open Surgery for Early-Stage Intrahepatic Cholangiocarcinoma After Mastering the Learning Curve: A Multicenter Data-Based Matched Study.

Authors:  Yang Jinhuan; Wang Yi; Zheng Yuanwen; Ma Delin; Chen Xiaotian; Wang Yan; Deng Liming; Yu Haitao; Wu Lijun; Deng Tuo; Chen Kaiyu; Hu Jiawei; Zheng Chongming; Wang Daojie; Jin Bin; Chen Gang
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

5.  Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review.

Authors:  Renato Patrone; Francesco Izzo; Raffaele Palaia; Vincenza Granata; Guglielmo Nasti; Alessandro Ottaiano; Gilda Pasta; Andrea Belli
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

6.  Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.

Authors:  Huiwu Xing; Bingqian Tan; Chenyu Yang; Mingman Zhang
Journal:  Front Med (Lausanne)       Date:  2022-03-30

7.  Generic surgical process model for minimally invasive liver treatment methods.

Authors:  Maryam Gholinejad; Egidius Pelanis; Davit Aghayan; Åsmund Avdem Fretland; Bjørn Edwin; Turkan Terkivatan; Ole Jakob Elle; Arjo J Loeve; Jenny Dankelman
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.